Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyrazolopyrimidines and substituted purines and their use as ubiquitin-specific-processing protease 1 (USP1) inhibitors

Substituted pyrazolopyrimidines and substituted purines and their use as ubiquitin-specific-processing protease 1 (USP1) inhibitors

US Patent 11485736 · Granted Nov 1, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

N2-phenylpyrimidine-2,4-diamine compounds, and preparation methods and methods o2025
Gene-regulating compositions and methods for improved immunotherapy2025
Protein kinase C inhibitors for treatment of uveal melanoma2025
Guide RNA combinations and methods of use2025
Gene-regulating compositions and methods for improved immunotherapy2024
Gene-regulating compositions and methods for improved immunotherapy2024
Methods for measuring and improving CRISPR reagent function2024
Substituted pyrazolopyrimidines and substituted purines and their use as ubiquit2023
Substituted pyrazolopyrimidines and substituted purines and their use as ubiquit2023
Substituted pyrazolopyrimidines and substituted purines and their use as ubiquit2023
Substituted pyrazolopyrimidines and substituted purines and their use as ubiquit2023
Gene-regulating compositions and methods for improved immunotherapy2023